Selvita S.A. Completes Acquisition of PozLab, Expanding Its Footprint in Pharmaceutical Manufacturing

Selvita S.A. announced  completion of a strategic transaction in which it has acquired 100% of shares in PozLab. The closing of the transaction comes ...

May 07, 2024 | Tuesday | News
Novartis Fortifies RLT Pipeline with Mariana Oncology Acquisition

Transaction reinforces company’s strategic focus on developing next-generation treatment options for patients living with cancer Mariana Oncology ...

May 03, 2024 | Friday | News
KKR Acquires Immedica Pharma, Spearheading Rare Disease Treatment Expansion

Investment funds managed by KKR, a leading global investment firm, have agreed to acquire Immedica Pharma, a pharmaceutical company headquartered in Stockh...

April 23, 2024 | Tuesday | News
Bruker Corporation to Acquire NanoString Technologies for $392.6 Million, Ensuring Continuity of Leading Life Science Tools

NanoString Technologies, Inc. (“NanoString” or “the Company”), a leading provider of life science tools for discovery and translati...

April 18, 2024 | Thursday | News
Blue Wolf Capital Partners to Acquire Seven European Manufacturing and Development Facilities from Recipharm

    The facilities, located in Solna, Stängnäs, Höganäs, Karlskoga, and Uppsala OTC Development in Sweden, Pessac in France...

April 03, 2024 | Wednesday | News
Genmab to Acquire ProfoundBio for USD 1.8 Billion in Cash

Genmab A/S (Nasdaq: GMAB) and ProfoundBio, Inc. have officially announced a definitive agreement for Genmab's acquisition of ProfoundBio in an all-cash dea...

April 03, 2024 | Wednesday | News
Maverix Medical Acquires Cirrus Bio to Spearhead Lung Cancer Diagnostics, Establishes Maverix Dx Division

Maverix Medical, a dedicated lung cancer platform established by Ajax Health, KKR, and Hologic, Inc.,  announced the acquisition of Cirrus Bio for an ...

April 01, 2024 | Monday | News
Indegene Bolsters Clinical and Regulatory Writing Expertise with Acquisition of Trilogy Writing & Consulting GmbH

Indegene, a digital-first, life sciences commercialization company, announced the acquisition of Trilogy Writing & Consulting GmbH (Trilogy), a global ...

March 28, 2024 | Thursday | News
Gilead Sciences Completes Acquisition of CymaBay, Strengthening Liver Disease Therapies

    “The acquisition of CymaBay brings us a potential best-in-disease therapy that could transform the treatment landscape for people wit...

March 25, 2024 | Monday | News
Lonza Strikes Deal with Roche: Acquires Genentech Facility in Vacaville for $1.2 Billion to Bolster Biologics Manufacturing Capacity

Lonza has signed an agreement to acquire the Genentech manufacturing facility in Vacaville (US) from Roche for USD 1.2 billion in cash Vacaville (US) si...

March 20, 2024 | Wednesday | News
AstraZeneca's Quantum Leap in Cancer Treatment: Acquires Fusion Pharmaceuticals for Next-Gen Radioconjugates

AstraZeneca has announced its definitive agreement to acquire Fusion Pharmaceuticals Inc., a trailblazing clinical-stage biopharmaceutical company speciali...

March 19, 2024 | Tuesday | News
Biocon Biologics Partners with Eris Lifesciences to Enhance Biosimilars Access in India

    Biocon Biologics Limited, a fully integrated global biosimilars company and a subsidiary of Biocon Limited (BSE code: 532523, NSE: BIOCON),...

March 14, 2024 | Thursday | News
Bruker Corporation Completes Acquisition of Chemspeed Technologies AG, Enhancing Automation and Digitalization Capabilities

Bruker Corporation (Nasdaq: BRKR) is pleased to announce the successful closing of its acquisition of Chemspeed Technologies AG, a leading Swiss provider o...

March 08, 2024 | Friday | News
ICIG Acquires Superabsorbents Business from Evonik in Multi-Million Euro Deal

ICIG acquires production facilities at five locations in Germany and U.S. Purchase price in low triple-digit million euro range Closing expected for mi...

March 05, 2024 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in